Baicalein decreased the expression of AKT, beta-catenin (CTNNB1), and cyclin D1 (CCND1), leading to the cell cycle arrest [31] and inhibiting the proliferation of HCC cells by suppressing the PI3K-Akt pathway [32]. Here, AKT1 is linked to hepatocellular carcinoma.